The Chinese State Food and Drug Administration (SFDA) has approved Victoza for the treatment of type 2 diabetes.
Diabet…
Articles by ASweetLife Team
JDRF Announces Children’s Congress 2011
Approximately 150 children and teenagers throughout the U.S., and several from around the world have been selected to tr…
Biodel to Accelerate Development of Ultra-Rapid-Acting Insulins
Biodel Inc. has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clin…
Raising Funds for Diabetes Research: Do You Have Something to Donate?
Help ASweetLife.org raise funds for diabetes research! We're collecting items and services to auction in Brenda Novak's…
GSK Type 1 Diabetes Drug, Otelixizumab, Fails in Phase 3 Study
GlaxoSmithKline and Tolerx, Inc's Investigatinal immunotherapy, Otelixizumab, for type 1 diabetes failed to meet primar…
Positive Results for Once Monthly Type 2 Diabetes Drug
Positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exen…
Just Peanuts
Many of your supermarket brand name peanut butters are not as good for you as they could be. While peanut butter is an …
Type 2 Diabetes Drug, ONGLYZA, Approved for Treatment of Renal Impairment by EU
The European Commission approved a label update for ONGLYZA® (saxagliptin) in the treatment of adults with type 2 diabet…
Abbott Announces Positive Results in Phase 2 Study of Atrasentan in Treatment of Diabetic Kidney Disease
Abbott has announced positive results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patient…
Amylin’s Type 2 Diabetes Drug, BYDUREON, Fails to Meet Primary End Point in New Study
Amylin Pharmaceuticals, Eli Lilly and Alkermes announced the top-line results from the DURATION-6 study comparing once w…
